Browse

Oral Presentation Abstracts

AHNS-071

HEAD AND NECK SURGEON’S PERCEPTION REGARDING PALLIATIVE CARE

Value / Quality

Yemeng Lu-Myers, MD, MPH, Rodney Taylor, MD

University of Maryland


AHNS-072

ASSOCIATION OF NEUTROPHIL-TO-LYMPHOCYTE RATIO DYNAMICS AND OUTCOMES WITH IMMUNE CHECKPOINT INHIBITION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

Systemic Therapy / Immunotherapy

Marcus A Couey, MD, DDS1, Mark T Schmidt, BSc1, Allen C Cheng, MD, DDS2, Ashish A Patel, MD, DDS2, R. Bryan Bell, MD, DDS1, Tanguy Y Seiwert, MD3, Rom S Leidner, MD1

1Earle A. Chiles Research Institute at Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, OR, 2Head and Neck Institute, Portland, OR, 3Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL


AHNS-073

THE EFFECT OF METFORMIN ON IMMUNE INFILTRATE IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

Mucosal - HPV Negative

Dev Amin, BS, Antonio Richa, MD, Mehri Mollaee, MD, Diana Whitaker-Menezes, MS, Tingting Zhan, PhD, Ulrich Rodeck, MD, PhD, Charalambos Solomides, MD, Robert Stapp, DO, Ubaldo Martinez-Outschoom, MD, PhD, Adam Luginbuhl, MD, David Cognetti, MD, Joseph Curry, MD

Thomas Jefferson University


AHNS-074

THE IMPACT OF NEOADJUVANT PRE-SURGICAL PD-1 INHIBITION ON THE IMMUNE PHENOTYPE IN PATIENTS WITH ORAL CAVITY CANCER.

Systemic Therapy / Immunotherapy

David M Neskey, MD, MSCR1, John Kaczmar, MD1, Hannah Knochelman, BS1, Megan Wyatt, BS1, Ying Xiong, PhD1, Michael Froehlich, BS1, Anvesh Kompelli, BS2, M. Rita Young, PhD1, Chrystal Paulos, PhD1

1Medical University of South Carolina, 2Louisiana State University ShreveportLouisiana State University Health - Shreveport School of Medicine


AHNS-075

PROGNOSTIC FACTORS ASSOCIATED WITH ACHIEVING TOTAL ORAL DIET FOLLOWING OSTEOCUTANEOUS MICROVASCULAR FREE TISSUE TRANSFER RECONSTRUCTION IN THE HEAD AND NECK

Reconstructive

Sagar Kansara, MD1, Tao Wang, PhD1, Sina Koochakzadeh, BS2, Nelson Liou, MD1, Mitchell Worley, MD2, Judith Skoner, MD2, Joshua Hornig, MD2, Terry Day, MD2, Andrew Huang, MD1

1Baylor College of Medicine, 2Medical University of South Carolina


AHNS-076

MORTALITY AND MORBIDITY IN PATIENTS 80 YEARS AND OLDER UNDERGOING MAJOR HEAD AND NECK ABLATION AND RECONSTRUCTION – A MULTI-INSTITUTIONAL STUDY

Reconstructive

Tanya Fancy, MD1, Jason Rich, MD2, Andrew Huang3, Rui Fernandes4, Evan Graboyes5, Jesse Ryan6, Mark Wax7

1West Virginia University, 2Washington University, 3Baylor College of Medicine, 4University of Florida, 5Medical University of South Carolina, 6Upstate University Health Systems, Syracuse, 7Oregon Health & Science University


AHNS-077

IDENTIFICATION OF HIGH-COST PATIENTS AFTER HEAD AND NECK CANCER SURGERY

Value / Quality

Michelle Chen, MD, Eben L Rosenthal, MD, Vasu Divi, MD

Stanford University


AHNS-078

EVALUATION OF REASONS FOR NCCN GUIDELINE NON-COMPLIANCE IN ADVANCED STAGE HEAD AND NECK CANCER

Value / Quality

Philip R Brauer, BA, Elliot Morse, BS, Joseph Earles, MD, Saral Mehra, MD, MBA

Yale School of Medicine


AHNS-079

DERIVING HEALTH UTILITY SCORES FROM HEAD AND NECK CANCER QUALITY OF LIFE INSTRUMENTS: MAPPING UWQOL AND EORTC QLQ-H&N35 ONTO EQ-5D AND HUI-3 INDICES

Value / Quality

Christopher W Noel, MD1, Robert F Stephens1, Jie Su2, Wei Xu, PhD2, Meredith Giuliani, MBBS, MEd2, Eric Monteiro, MD, MSc1, David Goldstein, MD, MSc1, John R de Almeida, MD, MSc1

1University of Toronto, Department of Otolaryngology - Head and Neck Surgery, 2University of Toronto, Department of Radiation Oncology


AHNS-080

INSURANCE COVERAGE CHANGE AND STAGE AT DIAGNOSIS AMONG NONELDERLY PATIENT WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA AFTER THE AFFORDABLE CARE ACT – NATIONAL CANCER DATABASE SURVEY

Value / Quality

Krupal B Patel, MD, MSc1, Caitlin McMullen, MD1, Kathryn Vorwald, DDS, MD1, Anthony C Nichols, MD2, Stephen Kang, MD3, James W Rocco, MD3, Matthew Old3

1Moffitt Cancer Center, 2Western University, 3The Ohio State University